Geron (GERN) Income from Continuing Operations (2010 - 2026)

Geron's (GERN) quarterly Income from Continuing Operations came in at 3568000.0 in Q1 2026, up 81.94% year-on-year from 1961129.12 in Q1 2025, and up 87.61% quarter-over-quarter from 28792000.0 in Q4 2025.

Geron (GERN) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Geron has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 3568000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 3568000.0, up 81.94% year-over-year; the trailing twelve-month figure through Mar 2026 was 66941000.0 (up 51.16% YoY), and the FY2025 annual result was 83125000.0, up 51.85% from the prior year.
  • Income from Continuing Operations came in at 3568000.0 for Q1 2026 at Geron, up from 28792000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3568000.0 in Q1 2026 to a low of 67320000.0 in Q2 2024.
  • The 5-year median for Income from Continuing Operations is 30042000.0 (2022), against an average of 34489941.18.
  • Across the five-year window, Income from Continuing Operations tumbled 68.39% in 2023 and jumped 81.94% in 2026, its largest moves.
  • Geron's Income from Continuing Operations stood at 42721000.0 in 2022, then retreated by 21.75% to 52014000.0 in 2023, then jumped by 54.63% to 23597000.0 in 2024, then declined by 22.02% to 28792000.0 in 2025, then jumped by 87.61% to 3568000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 3568000.0 (Q1 2026), 28792000.0 (Q4 2025), and 18267000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.97 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -14.46 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -3.40 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.03 Bn
9 Abivax 95.45 Bn 95.45 Bn - -56.48 Mn
10 Geron 753,046.88 753,046.88 - -3.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.57 Mn
Dec 31, 2025 -28.79 Mn
Sep 30, 2025 -18.27 Mn
Jun 30, 2025 -16.31 Mn
Mar 31, 2025 -19.75 Mn
Dec 31, 2024 -23.60 Mn
Sep 30, 2024 -26.38 Mn
Jun 30, 2024 -67.32 Mn
Mar 31, 2024 -55.33 Mn
Dec 31, 2023 -52.01 Mn
Sep 30, 2023 -44.71 Mn
Jun 30, 2023 -49.22 Mn
Mar 31, 2023 -38.16 Mn
Dec 31, 2022 -42.72 Mn
Sep 30, 2022 -40.91 Mn
Jun 30, 2022 -29.23 Mn
Mar 31, 2022 -30.04 Mn
Dec 31, 2021 -32.01 Mn
Sep 30, 2021 -26.62 Mn
Jun 30, 2021 -29.56 Mn